FACIT and Triphase Accelerator Announce New Partnership with Celgene
FACIT and Triphase Accelerator announced a new strategic collaboration with Celgene for a first-in-class pre-clinical therapeutic targeting the WDR5 protein for the treatment of blood cancers including leukemia.